What is he best known for?
The fields of study Erjia Liu is best known for:
- Gene
- Gene expression
- Messenger RNA
Erjia Liu integrates Signal transduction with Kinase in his research.
Erjia Liu integrates Kinase with Receptor tyrosine kinase in his research.
In his works, he performs multidisciplinary study on Receptor tyrosine kinase and Tyrosine kinase.
In his articles, Erjia Liu combines various disciplines, including Tyrosine kinase and Signal transduction.
He merges Molecular biology with Biochemistry in his research.
While working on this project, Erjia Liu studies both Biochemistry and Molecular biology.
AXL receptor tyrosine kinase is closely attributed to JAK-STAT signaling pathway in his study.
His research ties AXL receptor tyrosine kinase and JAK-STAT signaling pathway together.
Erjia Liu carries out multidisciplinary research, doing studies in Messenger RNA and RNA.
His most cited work include:
- The Transcriptional Landscape of the Mammalian Genome (3082 citations)
- axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. (562 citations)
What are the main themes of his work throughout his whole career to date
His study explores the link between Stage (stratigraphy) and topics such as Paleontology that cross with problems in Context (archaeology).
His Context (archaeology) study frequently links to related topics such as Paleontology.
His Endometrial cancer research extends to the thematically linked field of Genetics.
His Endometrial cancer study typically links adjacent topics like Genetics.
He incorporates Gene and Locus (genetics) in his research.
In his works, Erjia Liu undertakes multidisciplinary study on Locus (genetics) and Gene.
His Cancer research study typically links adjacent topics like Myeloid leukemia.
His Myeloid leukemia study frequently links to other fields, such as Cancer research.
Erjia Liu incorporates Cancer and Malignancy in his studies.
Erjia Liu most often published in these fields:
- Genetics (66.67%)
- Gene (58.33%)
- Cancer research (50.00%)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
